Page last updated: 2024-08-26

paxilline and Pulmonary Arterial Remodeling

paxilline has been researched along with Pulmonary Arterial Remodeling in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bálint, Z; Dahal, BK; Kwapiszewska, G; Murmann, K; Schermuly, RT; Seeger, W; Veith, C; Weissmann, N; Wygrecka, M; Zakrzewicz, D1

Other Studies

1 other study(ies) available for paxilline and Pulmonary Arterial Remodeling

ArticleYear
Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment.
    Thrombosis and haemostasis, 2014, Volume: 112, Issue:6

    Topics: Active Transport, Cell Nucleus; Animals; Antihypertensive Agents; Apoptosis; Becaplermin; Benzamides; Cell Adhesion; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Humans; Hypertension, Pulmonary; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Imatinib Mesylate; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Paxillin; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-sis; Pulmonary Artery; Pyrimidines; Receptor, Platelet-Derived Growth Factor beta; RNA Interference; Signal Transduction; Time Factors; Transfection; Tyrosine; Vascular Remodeling

2014